Netherton Syndrome Study Update: New Patients Added; Positive Nine-month ‘Whole Body’ Data October 28, 2025
AD Pipeline Update: Concerto Biosciences’ ENS-002 Shows Safety and Efficacy in Phase 1b Trial October 28, 2025
New Phase 3b Data Reinforce the Safety and Efficacy Profile of Ruxolitinib Cream in Moderate AD October 27, 2025
An Easy Pill to Swallow: PsO Patients, Providers Would Prefer Pill Over Injectables, Topicals October 27, 2025
Neutrogena Recalls Makeup Wipes Due to Potential Bacteria Contamination; Here’s What to Tell Your Patients October 25, 2025
Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD